LON:CTEC - ConvaTec Group Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started GBX 132.85 0.00 (0.00 %) (As of 04/23/2019 02:06 AM ET)Previous CloseGBX 132.85Today's RangeGBX 132.70 - GBX 136.3052-Week RangeGBX 113.25 - GBX 240.50Volume4.89 million shsAverage Volume5.44 million shsMarket Capitalization£2.61 billionP/E Ratio12.08Dividend Yield3.32%BetaN/A ProfileDiscussionAnalyst RatingsChartDividendInsider TradesHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as for traumatic injury, burns, invasive surgery, and other causes. The company also provides devices, accessories, and services for people with an ostomy or stoma resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity, and other causes. In addition, it offers continence and critical care products, including intermittent urinary catheters; and products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and urological disorders, as well as devices and products use in intensive care units and hospital settings. Further, the company provides advanced systems for managing acute fecal incontinence, as well as for monitoring urine production output and intra-abdominal pressure; and various disposable medical devices, such as wound drainage systems, urine collection bags and catheters, airway management and oxygen/aerosol therapy devices, suction handles and tubes, gastroenterology tubes, and securement devices. Additionally, it offers disposable infusion sets to the manufacturers of insulin pumps for diabetes, as well as similar pumps that are used in continuous infusion treatments for other conditions; and various products to hospitals and the home healthcare sector. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. The company was founded in 2008 and is headquartered in Reading, the United Kingdom. Receive CTEC News and Ratings via Email Sign-up to receive the latest news and ratings for CTEC and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange LON Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolLON:CTEC Previous Symbol CUSIPN/A CIKN/A Webwww.convatecgroup.com Phone44 11 8952 8100Debt Debt-to-Equity Ratio101.69 Current Ratio2.73 Quick Ratio1.72Price-To-Earnings Trailing P/E Ratio12.08 Forward P/E Ratio8.30 P/E GrowthN/A Sales & Book Value Annual Sales£1.83 billion Price / Sales1.42 Cash FlowGBX 16.10 per share Price / Cash Flow8.25 Book ValueGBX 82.40 per share Price / Book1.61Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees9,413 Outstanding Shares1,963,619,968Market Cap£2.61 billion Next Earnings DateN/A OptionableNot Optionable ConvaTec Group (LON:CTEC) Frequently Asked Questions What is ConvaTec Group's stock symbol? ConvaTec Group trades on the London Stock Exchange (LON) under the ticker symbol "CTEC." How often does ConvaTec Group pay dividends? What is the dividend yield for ConvaTec Group? ConvaTec Group announced a dividend on Thursday, February 14th. Stockholders of record on Thursday, April 4th will be given a dividend of GBX 3.10 per share on Thursday, May 16th. This represents a dividend yield of 2.58%. The ex-dividend date is Thursday, April 4th. This is a positive change from ConvaTec Group's previous dividend of $1.31. The official announcement can be accessed at this link. View ConvaTec Group's Dividend History. What price target have analysts set for CTEC? 10 equities research analysts have issued twelve-month price targets for ConvaTec Group's shares. Their predictions range from GBX 118 to GBX 230. On average, they expect ConvaTec Group's share price to reach GBX 172.80 in the next year. This suggests a possible upside of 30.1% from the stock's current price. View Analyst Price Targets for ConvaTec Group. What is the consensus analysts' recommendation for ConvaTec Group? 10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ConvaTec Group in the last year. There are currently 1 sell rating, 5 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for ConvaTec Group. Has ConvaTec Group been receiving favorable news coverage? Media coverage about CTEC stock has been trending negative on Tuesday, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. ConvaTec Group earned a media sentiment score of -2.3 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 2.0 out of 10, meaning that recent media coverage is very unlikely to have an impact on the stock's share price in the near term. Who are some of ConvaTec Group's key competitors? Some companies that are related to ConvaTec Group include Cochlear (COH), Fisher & Paykel Healthcare (FPH), Inspire Medical Systems (INSP), Draegerwerk AG & Co KGaA (DRW3), Stratec Biomedical (SBS), Avita Medical (AVH), Creo Medical Group (CREO), Medica Group (MGP), Hamilton Thorne (HTL), Helius Medical Technologies (HSM), Titan Medical (TMD), Advanced Oncotherapy (AVO), Kromek Group (KMK), Cyclopharm (CYC) and Impedimed (IPD). What other stocks do shareholders of ConvaTec Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other ConvaTec Group investors own include Enquest (ENQ), Centamin (CEY), Oxford BioMedica (OXB), Afren (AFR), Andalas Energy and Power (ADL), Genel Energy (GENL), Premier Oil (PMO), Playtech (PTEC), Talktalk Telecom Group (TALK) and Bristol-Myers Squibb (BMY). Who are ConvaTec Group's key executives? ConvaTec Group's management team includes the folowing people: Mr. Rick D. Anderson, Interim CEO & Non-Exec. Director (Age 58)Mr. Frank M. Schulkes, CFO & Director (Age 57)Mr. John Crosse, VP of Investor RelationsMr. Adam B. Deutsch, Exec. VP of Corp. Devel. & Gen. CounselMr. Douglas Le Fort, Sr. VP of Corp. Devel. (Age 53) How do I buy shares of ConvaTec Group? Shares of CTEC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is ConvaTec Group's stock price today? One share of CTEC stock can currently be purchased for approximately GBX 132.85. How big of a company is ConvaTec Group? ConvaTec Group has a market capitalization of £2.61 billion and generates £1.83 billion in revenue each year. ConvaTec Group employs 9,413 workers across the globe. What is ConvaTec Group's official website? The official website for ConvaTec Group is http://www.convatecgroup.com. How can I contact ConvaTec Group? ConvaTec Group's mailing address is 3 Forbury Place Floor 7, 23 Forbury Road, ICKENHAM, RG1 3JH, United Kingdom. The company can be reached via phone at 44 11 8952 8100. MarketBeat Community Rating for ConvaTec Group (LON CTEC)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 226 (Vote Outperform)Underperform Votes: 252 (Vote Underperform)Total Votes: 478MarketBeat's community ratings are surveys of what our community members think about ConvaTec Group and other stocks. Vote "Outperform" if you believe CTEC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CTEC will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 4/23/2019 by MarketBeat.com StaffFeatured Article: What is the Coverage Ratio?